Zobrazeno 1 - 10
of 29
pro vyhledávání: '"J. H. Hutchinson"'
Autor:
B. Stearns, C. D. King, I. DeArmond, J. Brittain, Y. P. Truong, J. H. Hutchinson, Jilly F. Evans, J. P. Hartung, K. Holme, G. Bain
Publikováno v:
The Journal of Clinical Pharmacology. 52:1482-1493
The prostaglandin D(2) receptor type 2 (DP2) and its ligand, PGD(2), have been implicated in the development of asthma and other inflammatory diseases. The authors evaluated the pharmacodynamics, pharmacokinetics and safety of [2'-(3-benzyl-1-ethyl-u
Autor:
T. Prueksaritanont, C. Fernandez-Metzler, Y. Meng, A. Barrish, W. Halczenko, S. B. Rodan, J. H. Hutchinson, M. E. Duggan, J. H. Lin
Publikováno v:
Xenobiotica. 34:103-115
Autor:
T, Prueksaritanont, C, Fernandez-Metzler, Y, Meng, A, Barrish, W, Halczenko, S B, Rodan, J H, Hutchinson, M E, Duggan, J H, Lin
Publikováno v:
Xenobiotica. 34:103-115
1. The disposition of 3-[2-oxo-3-[3-(5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yl) propyl]-imidazolidin-1-yl]-3(S)-(6-methoxy-pyridin-3-yl)propionic acid (compound A), a potent and selective alpha(v)beta(3) antagonist, was characterized in several anima
Autor:
JS Swaney, TJ Seiders, CS Baccei, P Fagan, Jillian F. Evans, A M Santini, PC Prodanovich, TA Parr, J. H. Hutchinson, LD Correa, DS Lorrain, RA Bundey, Petpiboon Prasit, C Chapman, KJ Stebbins
The aim of this study was to assess the potential of an antagonist selective for the lysophosphatidic acid receptor, LPA(1), in treating lung fibrosis We evaluated the in vitro and in vivo pharmacological properties of the high affinity, selective, o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feb659d2677e2bbd216e7d64f6d7bacc
https://europepmc.org/articles/PMC2936842/
https://europepmc.org/articles/PMC2936842/
Autor:
G. Bain, M Moran, P Schuilenga-Hut, P Prasit, K Schaab, J M Arruda, S van de Wetering de Rooij, D Shapiro, A F Roffel, G L Milne, DS Lorrain, A M Santini, C. D. King, Jilly F. Evans, Y Li, J. H. Hutchinson, M Rewolinski
Publikováno v:
Clinical pharmacology and therapeutics. 87(4)
The 5-lipoxygenase-activating protein (FLAP) gene and an increase in leukotriene (LT) production are linked to the risk of asthma, myocardial infarction, and stroke. We evaluated the pharmacodynamics, pharmacokinetics, and tolerability of 3-[3-tert-b
Autor:
T, Prueksaritanont, L M, Gorham, M J, Breslin, J H, Hutchinson, G D, Hartman, K P, Vyas, T A, Baillie
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 25(8)
The present study demonstrates the utility of an in vitro-in vivo correlative approach in the selection of an optimum prodrug candidate of L-767,679 (N-([7-(piperazin-1-yl)-3,4-dihydro-1(1H)-isoquinolinone-2-yl]acetyl)-3(S)-(ethynyl)-beta-alanine), a
Publikováno v:
Journal of lipid mediators. 6(1-3)
Autor:
J. H. Hutchinson, E. Campaigne
Publikováno v:
Journal of Heterocyclic Chemistry. 7:655-659
The reaction of sodium 2-amino-3-cyanoquinoline-4-carboxylate and 2-methyl-3-cyanoquino-line-4-carboxylic acid in polyphosphoric acid led to 2-amino- and 2-methylquinoline-3,4-dicar-boximide, respectively. Both of these compounds undergo imide N-alky
Publikováno v:
Inorganic Chemistry. 3:1525-1529
Publikováno v:
Inorganic Chemistry. 2:1255-1261